☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
gastroesophageal junction adenocarcinoma
Daiichi Sankyo and AstraZeneca's Enhertu Receive the US FDA's Approval for Previously Treated HER2-Positive Advanced Gastric Cance...
January 18, 2021
Prestige Signs an Exclusive Agreement with Teva to Commercialize Tuznue (biosimilar- trastuzumab) in Israel
November 11, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
